Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 21.125.79-22.6416.5114.91

What is the latest Core EBITDA Growth ratio of GLENMARK PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of GLENMARK PHARMACEUTICALS is 21.12 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202521.12
Mar20245.79
Mar2023-22.64
Mar202216.51
Mar202114.91

How is Core EBITDA Growth of GLENMARK PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 21.12
264.77
Mar2024 5.79
Positive
Mar2023 -22.64
Negative
Mar2022 16.51
10.73
Mar2021 14.91 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹57,529.3 Cr 3.7% 10.5% 30.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,982.0 Cr -0.7% -0.5% -3.1% Stock Analytics
DIVIS LABORATORIES ₹172,878.0 Cr 2.8% 2.2% 10.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,095.0 Cr 1.5% 3.4% 12.4% Stock Analytics
CIPLA ₹122,175.0 Cr 0.8% 0.1% 3.1% Stock Analytics
DR REDDYS LABORATORIES ₹107,154.0 Cr 0.4% 3.2% 0.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

3.7%

10.5%

30.6%

SENSEX

0.4%

-0.1%

6.1%


You may also like the below Video Courses